Tag: Michael J. Fox Foundation

What’s New In Parkinson’s Research

Over the last year, three promising new treatments for symptoms of Parkinson’s became available in the United States, but progress has been less hopeful on the development of drugs to modify the progression the disease, according to researchers who spoke at an annual movement disorders conference in San Diego ...

Read more

Let’s Talk About Parkinson’s

On Thursday and Friday, 23andMe will be participating in two online events hosted by the Michael J. Fox Foundation focused on Parkinson’s disease and some of the latest research into its genetic underpinning. On Thursday February 19th, at 12 pm EST, the Michael J. Fox Foundation will host a webinar titled ...

Read more

Highlights on New Parkinson’s Research

At an annual conference last month sponsored by the Michael J. Fox Foundation, scientists, academics and business representatives gathered in New York City to explore some of the latest and most promising research on Parkinson’s disease that’s being supported by the foundation. 23andMe’s Paul Cannon, who ...

Read more

New Parkinson’s Findings Published

A large new study spearheaded by researchers with the National Institute on Aging that involved scientists from more than 50 different institutions worldwide — including 23andMe — has found new genetic risks for Parkinson’s disease. Published in this week’s Nature Genetics, the study is significant for ...

Read more

Debate Around Informing Research Participants

This post comes to us from our friends at the Michael J. Fox Foundation, which has worked with us through our Parkinson’s Research Community. There are many different points of view on whether to inform research participants. For 23andMe our approach has always been to give customers and research participants ...

Read more

Parkinson’s Symptoms Different For Men and Women

(Editor's note: The first sentence in this post has been corrected. An editing error included the statement that preliminary research showed that onset for Parkinson's in women begins earlier. That is not the case. ) The 23andMe Parkinson’s Research Community continues to fuel insights into the disease, with ...

Read more

Getting In the Race

A friend of Gwen Schroeder once told her: “Don’t cheer from the sidelines if you can run the race.” So when her father was diagnosed with Parkinson’s disease, Gwen laced up her shoes. A post-production manager who works in New York City for the TED Conferences, Gwen signed up to run a marathon to raise ...

Read more

23andMe Reaches Parkinson’s Research Goal

We’re excited to announce that the 23andMe Parkinson’s Research Community has exceeded its goal, enrolling more than 10,000 people with the disease and creating the largest cohort of genotyped people with Parkinson’s in the world. Reaching this milestone offers scientists an incredible opportunity to better ...

Read more

23andMe’s Parkinson’s Research Featured on NPR

Our Parkinson’s research community got some welcome attention from NPR on Monday just as we are on the cusp of reaching our goal of enrolling 10,000 patients. The piece featured Emily Drabant, PhD, 23andMe’s research manager for our Parkinson’s community, and focused on our model of engaging patients as ...

Read more

23andMe’s Parkinson’s Community is Almost There

23andMe's Emily Drabant, PhD, speaking at a Parkinson's event in Iowa. 23andMe is tantalizingly close to reaching the goal of enrolling 10,000 patients in our Parkinson’s research community. We’re past the 8,000 mark and the pace of enrollment is now more than two-and-a-half times what was a year ago, but ...

Read more

Return to top